Mirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 13107-031-05
Published December 18, 2019 · Recall initiated: November 20, 2019
Summary
FDA records drug Class I recall D-0636-2020, published December 18, 2019 and initiated November 20, 2019. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 03119002A3, Exp 3/2022. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email if MIRTAZAPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIRTAZAPINE
- Manufacturer
- AuroMedics Pharma LLC
- Distributor
- Nationwide
- Lot
- Lot #: 03119002A3, Exp 3/2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton,April 22, 2020
- FDALidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDCDecember 18, 2019
- FDAHoney Mama s Truffle Bar (Trader Joe's) is a honey cocoa bar, refrigerated, one bar is packaged in flexibleDecember 18, 2019
- FDARanitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDCDecember 18, 2019
- FDAMirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, MylanMarch 15, 2017
- FDAMirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc,March 15, 2017
Questions about this recall
Was Mirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 13107-031-05 recalled?
Yes. FDA published recall D-0636-2020 on December 18, 2019. Reported hazard: Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIRTAZAPINE.